Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude ReubiEuropean journal of nuclear medicine and molecular imaging, 2020-04, Vol.47 (4), p.741-743 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2020). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04679-0 ;PMID: 32020369Full text available |
|
2 |
Material Type: Article
|
Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATEEuropean journal of nuclear medicine and molecular imaging, 2020-04, Vol.47 (4), p.881-894 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-019-04439-9 ;PMID: 31414209Full text available |
|
3 |
Material Type: Article
|
The Status of Neuroendocrine Tumor Imaging: From Darkness to Light?Neuroendocrinology, 2015-01, Vol.101 (1), p.1-17 [Peer Reviewed Journal]2015 S. Karger AG, Basel ;2015 S. Karger AG, Basel. ;Copyright (c) 2015 S. Karger AG, Basel ;ISSN: 0028-3835 ;ISSN: 1423-0194 ;EISSN: 1423-0194 ;DOI: 10.1159/000367850 ;PMID: 25228173 ;CODEN: NUNDAJFull text available |
|
4 |
Material Type: Article
|
Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imagingWorld journal of urology, 2022-02, Vol.40 (2), p.307-315 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0724-4983 ;EISSN: 1433-8726 ;DOI: 10.1007/s00345-021-03856-6 ;PMID: 34779884Full text available |
|
5 |
Material Type: Article
|
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practiceEuropean journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2358-2371 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04712-2 ;PMID: 32062681Full text available |
|
6 |
Material Type: Article
|
Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumorWorld journal of gastroenterology : WJG, 2009-12, Vol.15 (46), p.5867-5870Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;2009 The WJG Press and Baishideng. All rights reserved. 2009 ;ISSN: 1007-9327 ;EISSN: 2219-2840 ;DOI: 10.3748/wjg.15.5867 ;PMID: 19998512Full text available |
|
7 |
Material Type: Article
|
Peptide receptor radionuclide therapy of Merkel cell carcinoma using (177)lutetium-labeled somatostatin analogs in combination with radiosensitizing chemotherapy: a potential novel treatment based on molecular pathologyAnnals of nuclear medicine, 2012-05, Vol.26 (4), p.365-369 [Peer Reviewed Journal]EISSN: 1864-6433 ;DOI: 10.1007/s12149-012-0578-3 ;PMID: 22361935Full text available |
|
8 |
Material Type: Article
|
Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov databaseRadiation oncology (London, England), 2018-06, Vol.13 (1), p.113-113, Article 113 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1748-717X ;EISSN: 1748-717X ;DOI: 10.1186/s13014-018-1057-3 ;PMID: 29914515Full text available |
|
9 |
Material Type: Article
|
Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRIEuropean radiology, 2015-05, Vol.25 (5), p.1384-1391 [Peer Reviewed Journal]European Society of Radiology 2014 ;ISSN: 0938-7994 ;EISSN: 1432-1084 ;DOI: 10.1007/s00330-014-3536-8 ;PMID: 25447973Full text available |
|
10 |
Material Type: Article
|
Parental beliefs about children's teething in Udaipur, India: a preliminary studyBrazilian oral research, 2012-03, Vol.26 (2), p.151-157 [Peer Reviewed Journal]This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. ;ISSN: 1806-8324 ;ISSN: 1807-3107 ;EISSN: 1807-3107 ;DOI: 10.1590/S1806-83242012000200011 ;PMID: 22473351Full text available |
|
11 |
Material Type: Article
|
Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluationInternational journal of clinical and experimental pathology, 2014-01, Vol.7 (8), p.4971-4980IJCEP Copyright © 2014 2014 ;EISSN: 1936-2625 ;PMID: 25197368Full text available |
|
12 |
Material Type: Article
|
PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?Journal of Nuclear Medicine, 2021-09, Vol.62 (9), p.1242-1243 [Peer Reviewed Journal]Copyright Society of Nuclear Medicine Sep 1, 2021 ;2021 by the Society of Nuclear Medicine and Molecular Imaging. 2021 ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.121.262737 ;PMID: 34272320Full text available |
|
13 |
Material Type: Article
|
Tumor Lysis Syndrome: A Rare but Serious Complication of Radioligand TherapiesJournal of Nuclear Medicine, 2019-06, Vol.60 (6), p.752-755 [Peer Reviewed Journal]2019 by the Society of Nuclear Medicine and Molecular Imaging. ;Copyright Society of Nuclear Medicine Jun 1, 2019 ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.118.217380 ;PMID: 30464038Full text available |
|
14 |
Material Type: Article
|
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CTEuropean journal of nuclear medicine and molecular imaging, 2010-01, Vol.37 (1), p.67-77 [Peer Reviewed Journal]EISSN: 1619-7089 ;DOI: 10.1007/s00259-009-1205-y ;PMID: 19618183Full text available |
|
15 |
Material Type: Article
|
Biodistribution of [68Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour LesionsMolecular imaging and biology, 2016-06, Vol.18 (3), p.428-436 [Peer Reviewed Journal]World Molecular Imaging Society 2016 ;ISSN: 1536-1632 ;EISSN: 1860-2002 ;DOI: 10.1007/s11307-016-0945-x ;PMID: 27038316Full text available |
|
16 |
Material Type: Article
|
A Case-control Study for the Assessment of Correlation of Denture-related Sores and Oral Cancer RiskThe journal of contemporary dental practice, 2016-11, Vol.17 (11), p.930-933ISSN: 1526-3711 ;EISSN: 1526-3711 ;DOI: 10.5005/jp-journals-10024-1956 ;PMID: 27965503Full text available |
|
17 |
Material Type: Article
|
Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: An Immunohistochemical StudyThe journal of contemporary dental practice, 2016-10, Vol.17 (10), p.857-860ISSN: 1526-3711 ;EISSN: 1526-3711 ;DOI: 10.5005/jp-journals-10024-1944 ;PMID: 27794159Full text available |
|
18 |
Material Type: Article
|
Reply: 68 Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for ReplicationJournal of Nuclear Medicine, 2022-03, Vol.63 (3), p.493-494 [Peer Reviewed Journal]ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.121.263167 ;PMID: 35232881Full text available |
|
19 |
Material Type: Article
|
Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau diseaseEuropean journal of nuclear medicine and molecular imaging, 2016-10, Vol.43 (11), p.2014-2020 [Peer Reviewed Journal]EISSN: 1619-7089 ;DOI: 10.1007/s00259-016-3421-6 ;PMID: 27293206Full text available |
|
20 |
Material Type: Article
|
First Experiences with 177 Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single PatientsJournal of Nuclear Medicine, 2021-07, Vol.62 (7), p.975-978 [Peer Reviewed Journal]2021 by the Society of Nuclear Medicine and Molecular Imaging. ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.120.249029 ;PMID: 33246977Full text available |